Skip to main content
Erschienen in: Trials 1/2021

Open Access 01.12.2021 | COVID-19 | Letter

Effect of dexamethasone in patients with ARDS and COVID-19 – prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial

verfasst von: Jan Maláska, Jan Stašek, František Duška, Martin Balík, Jan Máca, Jan Hruda, Tomáš Vymazal, Olga Klementová, Jan Zatloukal, Tomáš Gabrhelík, Pavel Novotný, Regina Demlová, Jana Kubátová, Jana Vinklerová, Adam Svobodník, Milan Kratochvíl, Jozef Klučka, Roman Gál, Mervyn Singer, on behalf of the REMED Study Group

Erschienen in: Trials | Ausgabe 1/2021

download
DOWNLOAD
print
DRUCKEN
Metadaten
Titel
Effect of dexamethasone in patients with ARDS and COVID-19 – prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial
verfasst von
Jan Maláska
Jan Stašek
František Duška
Martin Balík
Jan Máca
Jan Hruda
Tomáš Vymazal
Olga Klementová
Jan Zatloukal
Tomáš Gabrhelík
Pavel Novotný
Regina Demlová
Jana Kubátová
Jana Vinklerová
Adam Svobodník
Milan Kratochvíl
Jozef Klučka
Roman Gál
Mervyn Singer
on behalf of the REMED Study Group
Publikationsdatum
01.12.2021
Verlag
BioMed Central
Schlagwort
COVID-19
Erschienen in
Trials / Ausgabe 1/2021
Elektronische ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-021-05116-9

Weitere Artikel der Ausgabe 1/2021

Trials 1/2021 Zur Ausgabe